AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in AN2 Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +14 vs. Q3 2023
- Shares held
- 20.4M
- +460.0K (+2.3%) vs. Q3 2023
- Total value
- $417.9M
- +$97.6M (+30.5%) vs. Q3 2023
- New holders
- 16
- 16 more added
- Sold out
- 2
- 10 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 63 | $1.29K | 0.00% | −2,982−97.9% | Reduced |
| Wells Fargo & Company | 126 | $2.58K | 0.00% | +64+103.2% | Added |
| Rhumbline Advisers | 250 | $5.12K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 258 | $5.29K | 0.00% | +160+163.3% | Added |
| Advisor Group Holdings, Inc. | 300 | $6.15K | 0.00% | +100+50.0% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 621 | $12.7K | 0.00% | +621 | New |
| FMR LLC | 670 | $13.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,331 | $68.3K | 0.00% | +546+19.6% | Added |
| Manufacturers Life Insurance Company, The | 9,842 | $201.7K | 0.00% | +9,842 | New |
| 683 Capital Management, LLC | 13,392 | $274.4K | 0.03% | +13,392 | New |
| Goldman Sachs Group Inc | 14,046 | $287.8K | 0.00% | +14,046 | New |
| Cubist Systematic Strategies, LLC | 16,483 | $337.7K | 0.00% | +16,483 | New |
| Man Group plc | 18,337 | $375.7K | 0.00% | +18,337 | New |
| Two Sigma Investments, LP | 19,248 | $394.4K | 0.00% | +19,248 | New |
| Balyasny Asset Management LLC | 19,285 | $395.1K | 0.00% | +19,285 | New |
| Bank of America Corp | 21,894 | $448.6K | 0.00% | +18,799+607.4% | Added |
| TD Asset Management Inc | 25,800 | $528.6K | 0.00% | +25,800 | New |
| ExodusPoint Capital Management, LP | 25,842 | $530.0K | 0.01% | +25,842 | New |
| Captrust Financial Advisors | 28,667 | $587.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 33,050 | $677.2K | 0.00% | +16,415+98.7% | Added |
| Monashee Investment Management LLC | 33,997 | $696.6K | 0.12% | −65,498−65.8% | Reduced |
| Bridgeway Capital Management, LLC | 36,992 | $758.0K | 0.02% | −10,508−22.1% | Reduced |
| State Street Corp | 38,302 | $784.8K | 0.00% | +22,900+148.7% | Added |
| Deutsche Bank AG | 39,472 | $808.8K | 0.00% | +39,472 | New |
| Millennium Management LLC | 39,674 | $812.9K | 0.00% | +39,674 | New |
| Laurion Capital Management LP | 43,814 | $897.7K | 0.03% | +43,814 | New |
| Barclays PLC | 44,238 | $906.4K | 0.00% | +41,068+1,295.5% | Added |
| RMB Capital Management, LLC | 45,942 | $941.4K | 0.03% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 50,000 | $1.02M | 0.01% | 00.0% | Unchanged |
| Victory Capital Management Inc | 51,660 | $1.06M | 0.00% | −440−0.8% | Reduced |
| Jane Street Group, LLC | 59,445 | $1.22M | 0.00% | +59,445 | New |
| Qube Research & Technologies Ltd | 72,208 | $1.48M | 0.00% | +72,208 | New |
| Susquehanna International Group, LLP | 99,404 | $2.04M | 0.00% | +75,141+309.7% | Added |
| Acuta Capital Partners, LLC | 132,000 | $2.70M | 1.52% | +118,700+892.5% | Added |
| Invesco Ltd. | 157,891 | $3.24M | 0.00% | −30,006−16.0% | Reduced |
| Citigroup Inc | 160,486 | $3.29M | 0.00% | +1,381+0.9% | Added |
| Geode Capital Management, LLC | 178,623 | $3.66M | 0.00% | +88,932+99.2% | Added |
| Price T Rowe Associates Inc | 187,399 | $3.84M | 0.00% | +187,399 | New |
| Nantahala Capital Management, LLC | 248,278 | $5.09M | 0.51% | −108,511−30.4% | Reduced |
| BlackRock Inc. | 305,841 | $6.27M | 0.00% | +263,679+625.4% | Added |
| Marshall Wace, LLP | 337,321 | $6.91M | 0.01% | −379,460−52.9% | Reduced |
| Octagon Capital Advisors LP | 664,575 | $13.6M | 2.18% | −203,000−23.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 900,672 | $18.5M | 0.04% | −4,884−0.5% | Reduced |
| Vanguard Group Inc | 1,052,591 | $21.6M | 0.00% | +112,700+12.0% | Added |
| Avidity Partners Management LP | 1,140,000 | $23.4M | 0.89% | +50,600+4.6% | Added |
| Janus Henderson Group PLC | 1,279,975 | $26.3M | 0.02% | −108,975−7.8% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,388,889 | $28.5M | 1.52% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,556,842 | $31.9M | 0.03% | +2900.0% | Added |
| BVF Inc | 1,563,963 | $32.0M | 0.80% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,678,209 | $54.9M | 6.09% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 5,551,295 | $113.7M | 1.78% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −41,046−100.0% | Sold out |
| Heritage Wealth Advisors | 0 | $0 | 0.00% | −1,060−100.0% | Sold out |